Reversion of naturally occurring high-level resistance mutations to NS3 protease inhibitors in two treatment-naive individuals infected with hepatitis C virus.
暂无分享,去创建一个
A. Lazzarin | H. Hasson | G. Morsica | M. Merli | S. Bagaglio | E. Messina | C. Uberti-Foppa | L. D. Torre